Acurx Pharmaceuticals Inc (ACXP)
2.20
+0.04
(+1.85%)
USD |
NASDAQ |
May 17, 10:59
Acurx Pharmaceuticals Stock Buybacks (Quarterly): -4.300M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -4.300M |
December 31, 2023 | -5.944M |
September 30, 2023 | 3.544M |
June 30, 2023 | -3.544M |
March 31, 2023 | 0.00 |
December 31, 2022 | -3.695M |
September 30, 2022 | |
June 30, 2022 | 0.00 |
March 31, 2022 |
Date | Value |
---|---|
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | -14.80M |
March 31, 2021 | |
December 31, 2020 | -0.7285M |
September 30, 2020 | -2.191M |
June 30, 2020 | -1.058M |
March 31, 2020 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-14.80M
Minimum
Jun 2021
3.544M
Maximum
Sep 2023
-2.337M
Average
-0.8931M
Median
Stock Buybacks (Quarterly) Benchmarks
Tonix Pharmaceuticals Holding Corp | -9.20M |
Seelos Therapeutics Inc | -4.477M |
PetVivo Holdings Inc | -1.383M |
NovaBay Pharmaceuticals Inc | -- |
Palatin Technologies Inc | -5.000M |